Precision Biosciences IncDTIL
Price$6.33Intrinsic value$11.3780% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $11.37median of 2 methodsbased on filings through 30 Jun 2026
Market Price $6.33Price as of 1 Oct 2026
Margin of Safety +79.7%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 23.6%/yr (balance of the path).19.6% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 622.8%Yr 722.0%Yr 821.2%Yr 920.4%Yr 1019.6%
23.6% → 19.6%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1117.9%Yr 1216.3%Yr 1314.6%Yr 1413.0%Yr 1511.3%Yr 169.6%Yr 178.0%Yr 186.3%Yr 194.7%Yr 203.0%
19.6% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 10.1%
Volatility vs market (adjusted beta)1.14

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetPrecision Biosciences IncDTILHealth Care
Valuation
P/E—
P/S4.1×
P/B4.1×
EV / Revenue2.2×
EV / EBITDA-0.6×
Profitability
Gross margin100.0%
Operating margin-152.0%
Net margin-117.0%
FCF margin-115.3%
Returns
ROE-116.4%
ROA-41.9%
ROIC—
Growth
Revenue growth (YoY)-34.4%
5-yr fwd EPS growth19.6%
Financial strength
Debt / Equity0.00×
Current ratio12.82×
Altman Z-Score-4.8
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.